Summary
The involvement of GABA-transaminase (GABA-T) in the blood-brain barrier to GABA was investigated using a sensitive radiotracer technique which allows measurement of tracer permeation as a cerebrovascular permeability-area product, PA. In Sprague-Dawley rats subjected to peripheral GABA-T inhibition and occlusion of hepatic circulation, chromatographic (TLC) analysis together with lyophylized plasma samples showed the radioactivity measured in brain parenchyma was derived from the permeation of unchanged [3H] GABA and not its blood-borne metabolites. Permeation (PA) of i.v. injected [3H] GABA was poor in all brain regions examined. Pretreatment of these rats with various compounds known to inhibit endothelial GABA-T activity did not cause any increased permeation of [3H] GABA into the brain. These results suggest that the poor permeation of GABA into the rat brain is unrelated to the activity of GABA-T at endothelial sites.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Battistan L, Erynbaum A, Lajtha A (1971) The uptake of various amino acids by the mouse brain in vivo. Brain Res 29:85–99
Björklund A, Falck B, Hromek F, Owman C (1969) An enzymic barrier mechanism for monoamine precursors in the newly formed capillaries following electrolytic or mechanical lesions. J Neurochem 16:1605–1608
Blasberg RG (1968) Specificity of cerebral amino acid transport: A kinetic analysis. In: Lajtha A, Ford DH (eds) Brain barrier systems. Prog Brain Res 29:245–258
Borisenko SA, Tolmacheva NS, Burov Y, Blinkova NF (1983) Permeability of the blood-brain barrier for [3H]-GABA in alcohol poisoning. Biull Eksp Biol Med 94:58–61
Bowery NG, Brown DA (1974) Depolarizing actions of γ-aminobutyric acid and related compounds on rat superior cervical ganglia in vitro. Br J Pharmacol 50:205–218
Dobbing J (1961) The blood-brain barrier. Physiol Rev 41:130–188
Djuricic BM, Rogac L, Spatz M, Rakic LM, Mrsulja BB (1978) Brain microvessels. I. Enzymic activities. Adv Neurol 20:197–205
Enna SJ, Maggi A, Worms P, Lloyd KG (1980) Muscimol: Brain penetration and anticonvulsant potency following GABA-T inhibition. In: Lal H (ed) GABA neurotransmission. Brain Res Bull [Suppl 2] 5:461–464
Ferkany JW, Butler IJ, Enna SJ (1979) Effects of drugs on rat brain, cerebrospinal fluid and blood GABA content. J Neurochem 33:29–33
Fowler LJ, John RA (1972) Active-site-directed irreversible inhibition of rat brain 4-aminobutyrate aminotransferase by ethanolamine-O-sulphate in vitro and in vivo. J Biochem 130:569–573
Frey HH, Löscher W (1980) Cetyl GABA: effect on convulsant thresholds in mice and acute toxicity. Neuropharmacol 19:217–220
Hespe JW, Roberts E, Prins H (1969) Autoradiographic investigation of the distribution of [14C] GABA in tissue of normal and aminooxyacetic acid-treated mice. Brain Res 14:663–671
Kerr DIB, Krantis A, Ong J (1983) GABA is a transmitter in the enteric nervous system. Proc Int Union Physiol Sci, vol 15. 29th Congress, Sydney, Australia
Krantis A (1982) GABA in the mammalian enteric nervous system. In: Okada Y, Roberts E (eds) Problems in GABA research. Excerpta Medica, Amsterdam, pp 128–136
Krantis A (1983a) Permeation of [3H] GABA into the rat brain: effects of GABA-transaminase inhibition. Soc Neurosci Abstr 9:1039
Krantis A (1983b) Hypothermia-induced reduction in the permeation of radiolabelled tracer substances across the blood-brain barrier. Acta Neuropathol (Berl) 60:61–69
Krause DN, Roberts E, Wong E, Degener P, Rogers K (1980) Specific cerebrovascular localization of GABA-related receptors and enzymes. Brain Res Bull 5:173–177
Krnjevic K (1974) Chemical nature of synaptic transmission in vertebrates. Physiol Rev 54:418–540
Krogsgaard-Larsen P, Schultz B, Mikkelsen H, Aaes-Jørgensen, Bøgesø KP (1981) THIP, isoguavacine, isoguavacine oxide and related GABA agonists. In: DeFendis FV, Mandel P (eds) Amino acid neurotransmitters. Raven Press, New York, pp 69–76
Kuriyama K, Haber B, Sisen B, Roberts E (1966) The γ-aminobutyric acid system in rabbit cerebellum. Proc Natl Acad Sci USA 55:846–852
Kuriyama K, Sze PY (1971) Blood-brain barrier to3H-γ-aminobutyric acid in normal and aminooxyacetic acid-treated animals. Neuropharmacology 10:103–108
Lloyd KG, Worms P, Depoortee H, Bartholini G (1979) Pharmacological profile of SL 76002, a new GABA-mimetic drug. In: Krogsgaard-Larsen P, Scheel-Krüger J, Kofod H (eds) GABA-neurotransmitters. Munksgaard, Copenhangen, pp 308–325
Lippert B, Jung MJ, Metcalf BW (1980) Biochemical consequences of reactions catalyzed by GAD and GABA-T. In: Lal H (ed) GABA neurotransmission. Brain Res Bull [Suppl 2] 5:375–379
Löscher W (1980) Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake and metabolism of GABA. J Neurochem 34:1603–1608
Löscher W (1982) Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action. Arch Int Pharmacodyn 257:32–58
Maggi A, Enna SJ (1979) Characteristics of muscimol accumulation in mouse brain after systemic administration. Neuropharmacology 18:361–366
Marazzi AS, Hart ER, Rodriguez JM (1958) Action of blood-borne gamma-aminobutyric acid on central synapses. Science 127:284–285
Meldrum BS (1975) Epilepsy and γ-aminobutyric acid-mediated inhibition. Int Rev Neurobiol 17:1–36
Mrsulja BB, Djuricic BM (1980) Biochemical characteristics of cerebral capillaries. In: Eisenberg HM, Suddith RL (eds) The cerebral microvasculature. Investigation of the blood-brain barrier. Adv Exp Med Biol 131:29–43
Obata K (1976) Excitatory effects of GABA. In: Roberts E et al. (eds) GABA in nervous system function. Raven Press, New York, pp 283–286
Ohno K, Pettigrew KD, Rapoport SI (1978) Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 235:299–307
Oldendorf WH (1971a) Brain uptake of radiolabelled amino acids, amines and hexoses after arterial injection. Am J Physiol 221:1629–1639
Oldendorf WH (1971b) Brain uptake of metabolites and drugs following carotid arterial injections. Trans Am Neurol Assoc 96:46–50
Orlowski M, Sessa G, Green JP (1974) γ-Glutamyl transpeptidase in brain capillaries: Possible site of a blood-brain barrier for amino acids. Science 184:66–68
Palfreyman MG, Schecter PJ, Buckett ER, Tell GP, Koch-Weser J (1981) The pharmacology of GABA-transaminase inhibitors. Biochem Pharmacol 30:817–824
Pardridge WM, Oldendorf WH (1977) Transport of metabolic substrates through the blood-brain barrier. J Neurochem 28:5–12
Perry TL, Hansen S, Kloster M (1973) Huntington's chorea. Defiency of γ-aminobutyric acid in the brain. New Engl J Med 288:337–342
Preston E, Haas N (1982) Test of a 2-compartment model for the assessment of blood-brain barrier permeability. Proc Can Fed Biol Soc 25:101P
Preston E, Allen M, Preston E (1983) A modified method for measurement of radiotracer permeation across the rat blood-brain barrier: the problem of correcting brain uptake for intravascular tracer. J Neurosci Methods 9:45–55
Purpura DP, Girado M, Smith TG, Gomez JA (1958) Effects of systemically administered ω-amino and guanidino acids on spontaneous and evoked cortical acrtical acrtivity in regions of bloodbrain barrier destruction. EEG Clin Neurophysiol 10:677–685
Rapoport SI (1976) Blood-brain barrier in physiology and medicine. Raven Press, New York
Rapoport SI, Ohno K, Fredericks WR, Pettigrew KD (1978) Regional cerebrovascular permeability to14C-sucrose after osmotic opening of the blood-brain barrier. Brain Res 150:653–657
Roberts E (1977) The γ-aminobutyric acid system and schizophrenia. In: Usdin E, Hamburg DA, Barchas JD (eds) Neuroregulators and psychiatric disorders. Oxford University Press, New York, pp 347–357
Schecter PJ, Grove J (1980) Biochemical and pharmacological similarities and differences among four irreversible enzymeactivated GABA-T inhibitors. Brain Res Bull [Suppl 2] 5:627–631
Svengaard NA, Björklund A, Haderbo JA, Stenevi U (1975) Axonal degeneration associatd with defective blood-brain barrier in cerebral implants. Nature 255:334–337
Van Gelder NM (1965a) The histochemical demonstration of γ-aminobutyric acid metabolism by reduction of a tetrazolium salt. J Neurochem 12:231–237
Van Gelder NM (1965b) A comparison of γ-aminobutyric acid metabolism in rabbit and mouse nervous tissue. J Neurochem 12:239–244
Van Gelder NM (1966) The effect of aminooxyacetic acid on the metabolism of gamma-aminobutyric acid in brain. Biochem Pharmacol 15:533–539
Van Gelder NM (1968) A possible enzyme barrier for γ-aminobutyric acid in the zentral nervous system. In: Lajtha A, Ford DH (eds) Brain-barrier systems. Prog Brain Res 29:259–268
Van Gelder NM, Elliott KAC (1958) Disposition of γ-aminobutyric acid administered to mammals. J Neurochem 3:139–143
Walters JR, Eng N, Pericic D, Miller JP (1978) Effects of amino-oxyacetic acid andl-glutamic acid-γ-hydrazide on GABA metabolism in specific brain regions. J Neurochem 30:759–766
Waszczak BL, Walters JR (1980) Effects of GABA-ergic drugs on single unit activity of A9 and A10 dopamine neurones. In: Lal H (ed) GABA neurotransmission. Brain Res Bull [Suppl 2] 5:465–470
Wu J (1981) Distribution and properties of GABA-synthesizing and degrading enzymes in non-neural tissues. In: Okada Y, Roberts E (eds) Recent advances in GABA study. International Symposium, Hakone, Japan, July 15–18
Wu J-Y, Moss LG, Chude O (1978) Distribution and tissue specificity of 4-aminoburyrate-2-oxoglutarate aminotransferase. Neurochem Res 3:207–219
Zweig G, Sherma J (1972) Handbook of chromatography, vol 1. Cleveland Rubber Co Press, Cleveland, Ohio
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krantis, A. The involvement of GABA-transaminase in the blood-brain barrier to radiolabelled GABA. Acta Neuropathol 64, 61–67 (1984). https://doi.org/10.1007/BF00695607
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00695607